Farther Finance Advisors’s Oragenics OGEN Stock Holding History
Bought
Maintained
Sold
Farther Finance Advisors's OGEN Position: Q3 2026 in Review
Farther Finance Advisors held its Oragenics (OGEN) position steady in Q3 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #6283.
Farther Finance Advisors first reported a position in OGEN in Q2 2025 and has held it in 4 quarters since. The position peaked at $4 in Q2 2025. 1 fund tracked by Wall St. Rank holds OGEN as of Q3 2026.
- Farther Finance Advisors held 1 share of Oragenics worth $0 as of Q3 2026.
- Farther Finance Advisors left its Oragenics share count unchanged in Q3 2026.
- Oragenics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #6283 holding.
- Farther Finance Advisors first reported a position in Oragenics in Q2 2025 and has held it in 4 quarters since.
- Farther Finance Advisors's Oragenics position peaked at $4 in Q2 2025.
- 1 fund tracked by Wall St. Rank held Oragenics as of Q3 2026.
Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.